Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID07230535

A Randomised Controlled Trial Comparing Wellbeing and Patient-Reported Outcomes After Robotic Single-Port Versus Open Nipple-Sparing Mastectomy with DIEP Reconstruction

Led by Beaumont Hospital · Updated on 2026-06-01

250

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the differences in patient-reported outcomes between robotic-assisted and conventional open nipple-sparing mastectomy (NSM) in women undergoing immediate breast reconstruction. This trial focuses on women with breast cancer or those at high risk, including genetic mutation carriers and those with ductal carcinoma in situ or early invasive breast cancer. The study aims to determine if the minimally invasive robotic approach offers better cosmetic results, body image, and satisfaction compared to the traditional open surgery. Both implant-based and autologous DIEP flap reconstructions are included to enhance the relevance of the findings. Participants will be randomly assigned to one of two treatment groups within separate reconstruction cohorts. One group receives robotic-assisted NSM using a single-port robotic system through a single axillary incision, performed at a central surgical hub. The other group undergoes standard open NSM through a conventional incision at either local or central sites depending on reconstruction needs. Immediate breast reconstruction follows the assigned NSM technique, either implant-based or DIEP flap. This multicenter study uses a hub-and-spoke model to provide access to robotic surgery while maintaining oncological safety. During the study, participants will be followed for up to 12 months postoperatively. Researchers will collect patient-reported outcomes using validated tools such as the Breast-Q, Hopwood Body Image Scale, and Aesthetic Item Scale to assess satisfaction, body image, and aesthetic results. Blinded assessors will evaluate aesthetic outcomes to reduce bias. Eligibility is carefully determined by clinical and radiological criteria to ensure appropriate candidates for NSM. The study also monitors safety and recovery, aiming to guide future patient care and surgical decision-making in breast cancer treatment.

CONDITIONS

Brief Title

Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 years and older
  • Selected for mastectomy and immediate DIEP flap reconstruction by the breast multidisciplinary team
  • Indications include genetic mutation carriers, ductal carcinoma in situ requiring mastectomy, or early invasive breast cancer
  • Tumor must not involve skin or nipple-areolar complex and no invasive disease within 1 cm of skin, nipple, or chest muscle as shown on MRI
  • Eligible for immediate DIEP reconstruction
  • Fluent in English
  • Fit for general anesthesia
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Advanced breast cancer with skin involvement for nipple-sparing mastectomy arms
  • Nipple involvement for nipple-sparing mastectomy arms
  • Prior chest wall radiation therapy
  • Pregnancy
  • Lactation
  • Insufficient English to provide informed consent without interpreter support

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Surgery day and immediate recovery period

Participants undergo either robotic-assisted or standard open nipple-sparing mastectomy with immediate breast reconstruction using either implant-based or DIEP flap reconstruction.

1 surgical visit (in-person)

Post-operative Follow-up

Duration - Up to 12 months post operative

Participants are followed after surgery to monitor recovery and assess patient-reported outcomes including wellbeing and aesthetic results.

Multiple follow-up visits up to 12 months

Trial Site Locations

Total: 1 location

1

Beaumont RCSI Cancer Centre

Beaumont, Ireland, D09

Actively Recruiting

Loading map...

Research Team

T

Trudi Nelson Roche

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Prospective, Multicenter, Controlled Clinical Study of 3D-...

Breast Cancer

Actively Recruiting

1 location

Acellular Dermal Matrix Investigation in Breast Reconstructi...

Breast Reconstruction

Actively Recruiting

13 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation.

Antonio Toesca, Claudia Sangalli, Patrick Maisonneuve...

https://pubmed.ncbi.nlm.nih.gov/34597010